We report a powerful new technique: hyphenating synchrotron X-ray powder diffraction (XRD) with differential scanning calorimetry (DSC). This is achieved with a simple modification to a standard laboratory DSC instrument, in contrast to previous reports which have involved extensive and complex modifications to a DSC to mount it in the synchrotron beam. The high-energy X-rays of the synchrotron permit the recording of powder diffraction patterns in as little as 2 s, meaning that thermally induced phase changes can be accurately quantified and additional insight on the nature of phase transitions obtained. Such detailed knowledge cannot be gained from existing laboratory XRD instruments, since much longer collection times are required. We de...
Differential scanning calorimetry (DSC) is a well-established method to study energetic changes in s...
The thermal and structural evolutions associated to active pharmaceutical ingredient (API) purity ar...
Flufenamic acid (FFA) is a highly polymorphic drug molecule with nine crystal structures reported in...
© 2016 American Chemical Society. We report a powerful new technique: hyphenating synchrotron X-ray ...
We report a powerful new technique: hyphenating synchrotron X-ray powder diffraction (XRD) with diff...
We report a powerful new technique: hyphenating synchrotron X-ray powder diffraction (XRD) with diff...
The polymorphic behavior of lard was systematically investigated by differential scanning calorimetr...
Differential scanning calorimetry (DSC) is a well-established technique to monitor energetic changes...
Coupling of time-resolved synchrotron X-ray diffraction at both small and wide angles with different...
Co‐crystallisation is widely explored as a route to improve the physical properties of pharmaceutica...
Amorphous solid dispersions (ASDs) are single-phase amorphous systems, where drug molecules are mole...
X-ray analysis confirmed that in all investigated samples, the active API (acetylsalicylic acid and ...
Differential scanning calorimetry (DSC) is a well-established method to study energetic changes in s...
Powder diffraction is one of the fundamental techniques for the investigation of materials. Its sens...
Flufenamic acid (FFA) is a highly polymorphic drug molecule with nine crystal structures reported in...
Differential scanning calorimetry (DSC) is a well-established method to study energetic changes in s...
The thermal and structural evolutions associated to active pharmaceutical ingredient (API) purity ar...
Flufenamic acid (FFA) is a highly polymorphic drug molecule with nine crystal structures reported in...
© 2016 American Chemical Society. We report a powerful new technique: hyphenating synchrotron X-ray ...
We report a powerful new technique: hyphenating synchrotron X-ray powder diffraction (XRD) with diff...
We report a powerful new technique: hyphenating synchrotron X-ray powder diffraction (XRD) with diff...
The polymorphic behavior of lard was systematically investigated by differential scanning calorimetr...
Differential scanning calorimetry (DSC) is a well-established technique to monitor energetic changes...
Coupling of time-resolved synchrotron X-ray diffraction at both small and wide angles with different...
Co‐crystallisation is widely explored as a route to improve the physical properties of pharmaceutica...
Amorphous solid dispersions (ASDs) are single-phase amorphous systems, where drug molecules are mole...
X-ray analysis confirmed that in all investigated samples, the active API (acetylsalicylic acid and ...
Differential scanning calorimetry (DSC) is a well-established method to study energetic changes in s...
Powder diffraction is one of the fundamental techniques for the investigation of materials. Its sens...
Flufenamic acid (FFA) is a highly polymorphic drug molecule with nine crystal structures reported in...
Differential scanning calorimetry (DSC) is a well-established method to study energetic changes in s...
The thermal and structural evolutions associated to active pharmaceutical ingredient (API) purity ar...
Flufenamic acid (FFA) is a highly polymorphic drug molecule with nine crystal structures reported in...